Much has been written lately about the rush to quickly make new coronavirus research available to the medical community, government agencies, and the concerned public. Recent news and analysis ranges from scholarly publishers working together to maximize the efficiency of peer review, to a demand for conclusiveness against an “infodemic” of both accurate and inaccurate guidance, to our own observations that preprints and media attention are driving rapid publication like never before.
